AI
IBM stops new sales of its AI-based Watson Health Drug Discovery platform
IBM Corp.’s Watson Health business unit will wind down its Drug Discovery service, which is used by pharmaceutical companies to apply artificial intelligence to the development of new medicines. Medical news journal Stat first…